Monday, February 24, 2020

A strategic solution that's proven to speed study launches



It’s no surprise that the overwhelming majority of clinical trials experience significant delays.

Clinical trials involve massive complexity and, often, systems that lack consistency and discipline.

The WCG Study Fast-Start solution provides coordinated execution of six proven strategies that dramatically and consistently bring clinical studies to launch faster and at a lower cost.









How WCG accelerates study cycles to provide your competitive advantage



Every clinical study sponsor strives to achieve the shortest possible study cycle. Yet fully 80% of trials fall behind. The reason for delays and missed deadlines is rarely a single problem.

Study launches are nearly always inhibited by a constellation of variables: Sluggish IRB reviews, fraught contract negotiations, poor-performing sites, too few recruitment staff, too small a patient pool, inadequate enrollment skills, or insensitive informed consent.

To address the variety of obstacles that may inhibit your clinical trial, our Fast Start Solution identifies the key causes—or potential causes—likely to slow your study launch. We then recommend specific acceleration services to overcome each of your obstacles and put the study on a fast track.

If your trial is running behind—or you want to leap-frog delays for your next study—let us analyze your study and offer services that can reduce average launch times by 33% across all therapeutic indications.


red yeezys red yeezys new yeezys black yeezy black yeezy yeezys for sale yeezys price yeezy boost 350 for sale yeezy boost 350 for sale cheap yeezys yeezy shoes for sale yeezy sneakers|yeezys shoes fake yeezys fake yeezys fake yeezys kanye west sneakers kanye west shoes kanye shoes yeezy sneakers yeezy shoes